Table 2.

Comparison of Marfan patients in GenTAC who completed the SF-36 versus those who did not

		Completed SF-36	No SF-36	p-value
Age at enrollment	18–39 years	192 (49.4%)	158(62.2%)
	40–69 years	183 (47.0%)	92 (36.2%)
	≥70 years	16 (4.2%)	4 (1.6%)	0.004
Gender	Male	199 (51.2%)	142 (55.9%)	0.2
Race	White	356 (91.5%)	217 (85.4%)
	Black	16 (4.1%)	19 (7.5%)
	Asian	10 (2.6%)	10 (3.9%)
	Other	7 (1.8%)	8 (3.1%)	0.1
MFS severity score	Mild (0–2)	27 (6.9%)	33 (13%)
	Typical (3–8)	200 (51.4)	146 (57.5%)
	Severe (9+)	162 (41.7%)	75 (29.5%)	0.001
Age at diagnosis	mean (standard deviation)	21 (15.8)	18.1 (14.2)	0.03